MGP
EW icon

Metis Global Partners’s Edwards Lifesciences EW Stock Holding History

Metis Global Partners’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.28M Sell
25,194
-774
-3% -$64.8K 0.05% 281
2026
Q1 		$2.08M Sell
25,968
-1,372
-5% -$113K 0.05% 291
2025
Q4 		$2.33M Sell
27,340
-3,689
-12% -$303K 0.06% 287
2025
Q3 		$2.41M Sell
31,029
-1,408
-4% -$110K 0.06% 287
2025
Q2 		$2.54M Sell
32,437
-14,081
-30% -$1.05M 0.07% 264
2025
Q1 		$3.37M Buy
46,518
+2,407
+5% +$172K 0.09% 189
2024
Q4 		$3.27M Buy
44,111
+2,902
+7% +$203K 0.1% 174
2024
Q3 		$2.72M Buy
41,209
+3,340
+9% +$243K 0.08% 211
2024
Q2 		$3.5M Buy
37,869
+306
+0.8% +$27.1K 0.12% 141
2024
Q1 		$3.59M Sell
37,563
-107
-0.3% -$8.99K 0.13% 129
2023
Q4 		$2.87M Buy
37,670
+3,024
+9% +$210K 0.11% 159
2023
Q3 		$2.4M Buy
34,646
+4,231
+14% +$340K 0.12% 175
2023
Q2 		$2.87M Buy
30,415
+842
+3% +$73.2K 0.15% 132
2023
Q1 		$2.45M Buy
29,573
+6,249
+27% +$491K 0.16% 131
2022
Q4 		$1.74M Buy
23,324
+10,243
+78% +$789K 0.16% 140
2022
Q3 		$1.08M Buy
13,081
+1,682
+15% +$162K 0.17% 134
2022
Q2 		$1.08M Buy
11,399
+1,533
+16% +$159K 0.17% 134
2022
Q1 		$1.16M Buy
9,866
+4,431
+82% +$497K 0.14% 136
2021
Q4 		$704K Buy
+5,435
New +$634K 0.2% 122

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Metis Global Partners's EW Position: Q2 2026 in Review

Metis Global Partners reduced its Edwards Lifesciences (EW) stake by 3% in Q2 2026, selling an estimated $64.8K and leaving 25,194 shares worth $2.28M. The position accounts for 0.05% of the portfolio, ranked #281.

Metis Global Partners first reported a position in EW in Q4 2021 and has held it in 19 quarters since. The position peaked at $3.59M in Q1 2024. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Metis Global Partners held 25,194 shares of Edwards Lifesciences worth $2.28M as of Q2 2026.
  • Metis Global Partners sold 774 Edwards Lifesciences shares in Q2 2026, an estimated $64.8K.
  • Edwards Lifesciences made up 0.05% of Metis Global Partners's portfolio in Q2 2026, its #281 holding.
  • Metis Global Partners first reported a position in Edwards Lifesciences in Q4 2021 and has held it in 19 quarters since.
  • Metis Global Partners's Edwards Lifesciences position peaked at $3.59M in Q1 2024.
  • 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Metis Global Partners's 13F filing for Q2 2026, filed 10 Aug 2026.